Omalizumab for the Treatment of Multiple Food AllergiesRobert A. Wood, R. Sharon Chinthrajah, Agustin Calatroni et al.|New England Journal of Medicine|2024Cited by 298
Effect of Epicutaneous Immunotherapy vs Placebo on Reaction to Peanut Protein Ingestion Among Children With Peanut AllergyDavid M. Fleischer, Wayne G. Shreffler, Matthew Greenhawt et al.|JAMA|2019Cited by 271
Phase 3 Trial of Epicutaneous Immunotherapy in Toddlers with Peanut AllergyMatthew Greenhawt, Paul Turner, Sayantani Sindher et al.|New England Journal of Medicine|2023Cited by 129
Food protein–induced enterocolitis syndrome in the US population–based studyAnna Nowak‐Węgrzyn, Ruchi S. Gupta, Christopher Warren et al.|Journal of Allergy and Clinical Immunology|2019Cited by 116
Long-term, open-label extension study of the efficacy and safety of epicutaneous immunotherapy for peanut allergy in children: PEOPLE 3-year resultsDavid M. Fleischer, Hugh A. Sampson, Wayne G. Shreffler et al.|Journal of Allergy and Clinical Immunology|2020Cited by 101